Akari Therapeutics (NASDAQ: AKTX) continues to execute on its strategy of advancing a differentiated payload platform designed for the next generation of antibody drug conjugates (ADCs). The

Ahead of Alphabet's Q2 2026 earnings on July 22, the convergence of strong growth drivers and mounting competitive risks is expected to drive high volatility, which active traders can target

Immersed is building a next-generation spatial computing platform that combines AR/VR software, AI productivity tools, and its Visor headset to redefine remote work. With 1.5 million users, $

Every investor has to weigh the evidence for themselves. But the evidence here is unusually legible: founders of major technology companies invested. More than 10,000 investors followed with over $37 million....

A watchlist this wide only works if you can trade all of it in one place, and the more of it you trade. As a global multi-asset broker, PrimeXBT gives traders access to more than 350 markets across Forex,...

Qualcomm's upcoming earnings could drive significant volatility, with Direxion's QCMU and QCMD ETFs offering leveraged ways to trade the move.

Microsoft's AI-fueled earnings could spark major stock moves, with Direxion's MSFU and MSFD ETFs offering leveraged ways to trade the volatility.

As AI infrastructure spending surges, EMS leaders TTM Technologies and Celestica are benefiting from booming demand for data center hardware, with Tradr's new 2X leveraged ETFs offering ampli

Immersed is building a virtual workspace platform that combines software, AI, and wearable hardware, giving investors an opportunity to back its vision for the future of computing while it's

Cytonics is developing a potential first-in-class therapy designed to target the root cause of osteoarthritis, offering investors a chance to participate ahead of a limited-time funding deadl